Comparison of Efficacy of Baricitinib and Dupilumab in the Treatment of Chinese Moderate-To-Severe Atopic Dermatitis: A Retrospective Study.

Bo Liu,Xiaoting Song,Shuanglu Liao,Tingting Luan,Zuotao Zhao

International archives of allergy and immunology（2023）

引用 0|浏览3

暂无评分

摘要

The efficacy of baricitinib at a dose of 2 mg daily was similar to dupilumab, and the improvement in pruritus was significantly faster in the early stage of treatment (the first 4 weeks) than that of dupilumab.

查看译文

关键词

Atopic dermatitis, Baricitinib, Dupilumab, Retrospective cohort study

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要